Krebs Biochemicals & Industries (BOM:524518) Tariff Resilience Score: 0/10 (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524518 Krebs Biochemicals & Industries Ltd BOM:524518
40 GF Score
Price ₹55.90
GF Value ₹37.76
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Krebs Biochemicals & Industries Tariff Resilience Score?

Krebs Biochemicals & Industries has the Tariff Resilience Score of 0, which implies that the company might have .

Krebs Biochemicals & Industries has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Krebs Biochemicals & Industries might have .


Krebs Biochemicals & Industries  (BOM:524518) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Krebs Biochemicals & Industries Tariff Resilience Score Related Terms

BOM:524518
40GF Score
Krebs Biochemicals & Industries Ltd BOM:524518
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Krebs Biochemicals & Industries (BOM:524518) Overvalued in 2026?

Based on GuruFocus' analysis, Krebs Biochemicals & Industries stock appears to be overvalued. The current stock price of ₹55.90 is trading 48% above its estimated GF Value™ of ₹37.76. GuruFocus considers Krebs Biochemicals & Industries to be Significantly Overvalued.

Key valuation signals for BOM:524518:

  • Tariff Resilience Score: 0
  • GF Value™: ₹37.76 vs. price of ₹55.90 (48% above fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the BOM:524518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krebs Biochemicals & Industries Business Description

Other Exchanges KREBSBIO:India
Address Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, AP, IND, 531 031
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.
40GF Score

Get the complete analysis for BOM:524518

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹55.90
Price
₹37.76
GF Value